OTC Innovations USA 1999-2009: Analysis of Factors
for Success
Published March 2010
View
PDF brochure
View
fact sheet
A comprehensive assessment of new product introductions
in the U.S. nonprescription drugs industry over the
past ten years, including new ingredients, new technologies,
new indications/claims, "ease of use" improvements,
and innovative product delivery technologies.
Analysis is based on Kline's Innovation Index, which
quantifies how innovative a product or company is based
on various innovation factors. (Y663)
TABLE OF CONTENTS |
 |
|
 |
|
|
Introduction
Executive Summary
Innovations by Product Class and Brand
Digestive products
Feminine products
Internal analgesics
Nutritional products
Upper respiratory
Innovations by Company
Barr Laboratories
Bayer Group
Boehringer-Ingelheim
GlaxoSmithKline
Johnson & Johnson
Merck
Novartis
Pfizer
Procter & Gamble
Reckitt Benckiser
Innovations by Type
New ingredients
New claims/indications
New drug delivery technologies
"Ease of use" improvements
|
Contact
|
